Guangzhou Huajin Pharmaceutical Technology Co.
Latest round
- Series B
Last raised
- Dec 2023
Total raised
- Undisclosed
Investors
- 5
About Guangzhou Huajin Pharmaceutical Technology Co.
, Ltd. operates as a biotechnology company that focuses on the development and production of biological oncology drugs.S. FDA, China Taiwan TFDA and China NMPA, and initiated international multi-center Phase I/IIa clinical trials for a variety of malignant solid tumors during 2021. The company focuses on the research and development of biological anti-tumor innovative drugs in the bacterial vector class. Currently, it has developed SalMet-Vec, a self-developed lysogenic bacterium, which is a genetically engineered biologic product that carries and expresses methioninase through attenuated Salmonella vectors, and exerts precisely targeted anti-tumor effects in the direction of the metabolic regulation of amino acids required for tumor growth. As the Company's pioneering core product, SalMet-Vec has already obtained IND approvals and entered the clinical trial stage in China, the United States and other places.
Who invested in Guangzhou Huajin Pharmaceutical Technology Co.
5 investors across 3 rounds
See all investors in Guangzhou Huajin Pharmaceutical Technology Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Guangzhou Huajin Pharmaceutical Technology Co.
Who invested in Guangzhou Huajin Pharmaceutical Technology Co.?
Guangzhou Huajin Pharmaceutical Technology Co. has 5 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Guangzhou Huajin Pharmaceutical Technology Co. raised?
Guangzhou Huajin Pharmaceutical Technology Co. has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Guangzhou Huajin Pharmaceutical Technology Co. last raise money?
Guangzhou Huajin Pharmaceutical Technology Co.'s most recent round on record is a Series B, in Dec 2023.
What does Guangzhou Huajin Pharmaceutical Technology Co. do?
Guangzhou Huajin Pharmaceutical Technology Co. is a biotechnology company.
Where is Guangzhou Huajin Pharmaceutical Technology Co. headquartered?
Guangzhou Huajin Pharmaceutical Technology Co. is headquartered in Guangzhou, China.
Which VCs invest in companies like Guangzhou Huajin Pharmaceutical Technology Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Guangzhou Huajin Pharmaceutical Technology Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Guangzhou Huajin Pharmaceutical Technology Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.